REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 81 filers reported holding REPROS THERAPEUTICS INC in Q2 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $248,000 | -13.9% | 28,900 | 0.0% | 0.00% | – |
| Q4 2014 | $288,000 | -14.8% | 28,900 | -15.2% | 0.00% | – |
| Q3 2014 | $338,000 | -45.6% | 34,100 | -5.0% | 0.00% | -100.0% |
| Q2 2014 | $621,000 | -2.5% | 35,900 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $637,000 | +12.9% | 35,900 | +16.6% | 0.00% | 0.0% |
| Q4 2013 | $564,000 | -96.8% | 30,801 | -95.3% | 0.00% | -94.1% |
| Q3 2013 | $17,486,000 | +56.5% | 652,449 | +7.7% | 0.02% | +41.7% |
| Q2 2013 | $11,175,000 | – | 605,666 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,001,000 | $970,000 | 0.21% |
| Allegis Investment Advisors, LLC | 341,669 | $331,000 | 0.19% |
| GENERAL AMERICAN INVESTORS CO INC | 396,123 | $384,000 | 0.04% |
| Alambic Investment Management, L.P. | 114,591 | $111,000 | 0.04% |
| Gruss Capital Management LP | 600,000 | $582,000 | 0.02% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 102,086 | $99,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 323,429 | $314,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,931 | $27,000 | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $3,000 | 0.00% |
| Airain ltd | 13,690 | $13,000 | 0.00% |